Biostage to Host Conference Call to Provide Business Update

February 6, 2018

Responsive image

HOLLISTON, Mass., Feb. 6, 2018 /PRNewswire/ — Biostage, Inc. (OTCQB: BSTG), a biotechnology company developing bioengineered organ implants to treat life-threatening conditions of the esophagus, bronchus and trachea, today announced that on Tuesday, February 13, 2018 at 9:00 AM ET it…

Category: Precious Metals